Australia markets open in 2 hours 10 minutes

Harvard Bioscience, Inc. (HBI.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.4400+0.0200 (+0.58%)
At close: 05:30PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 148.64M
Enterprise value 184.45M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.39
Price/book (mrq)2.18
Enterprise value/revenue 1.64
Enterprise value/EBITDA 22.96

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3-32.28%
S&P500 52-week change 325.59%
52-week high 35.6500
52-week low 33.2600
50-day moving average 33.7652
200-day moving average 34.0053

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 543.42M
Implied shares outstanding 643.46M
Float 835.08M
% held by insiders 17.28%
% held by institutions 178.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -8.18%
Operating margin (ttm)-9.30%

Management effectiveness

Return on assets (ttm)-0.69%
Return on equity (ttm)-12.20%

Income statement

Revenue (ttm)106.79M
Revenue per share (ttm)2.50
Quarterly revenue growth (yoy)-18.20%
Gross profit (ttm)N/A
EBITDA 5.53M
Net income avi to common (ttm)-8.73M
Diluted EPS (ttm)-0.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.25M
Total cash per share (mrq)0.1
Total debt (mrq)35.61M
Total debt/equity (mrq)51.75%
Current ratio (mrq)1.88
Book value per share (mrq)1.59

Cash flow statement

Operating cash flow (ttm)13.62M
Levered free cash flow (ttm)14.97M